Chemours jumps 10% to $26.52 as upgrades pile up ahead of May earnings
Chemours (NYSE: CC) is jumping about 10% to $26.52 as investors position ahead of its May 5, 2026 quarterly results, with the stock recently notching fresh 12-month highs. The rally is being reinforced by a wave of April analyst target-price increases, including a move to $29 and another to $27.
1) What’s moving shares today
Shares of The Chemours Company (CC) are up roughly 10% in the latest session, extending a late-April breakout that has pushed the stock to new 12-month highs. The move appears driven by a combination of (1) positioning into the company’s next earnings report (results are scheduled after the close on Tuesday, May 5, 2026, with a webcast call on May 6) and (2) a string of recent bullish target-price increases that have pulled incremental buyers back into the name. (chemours.com)
2) The catalyst: upgrade momentum meets a technical breakout
Chemours has benefited from multiple price-target raises in April, highlighted by targets lifted to $29 and $27, helping reset sentiment after earlier volatility. As the stock climbed, the technical picture improved, and the latest push higher is consistent with momentum accounts and short-covering behavior that often follows a fresh 52-week high. (stockanalysis.com)
3) What investors are watching next
The next major fundamental checkpoint is Chemours’ first-quarter 2026 earnings release on May 5, 2026. With the stock now well above recent moving averages, traders are likely to focus on management commentary around 2026 demand trends and the company’s ability to sustain margins into mid-year, while longer-term investors continue to weigh balance-sheet actions and environmental-liability overhangs. (chemours.com)